Advanced Search

Oncology & Hematology Coding Alert

Drug Coding:

Prepare in Advance for Potential 2013 HCPCS Updates

Published on Tue Jun 12, 2012

Factor these RiaSTAP code changes into your summer and winter plans. If you treat lymphoma, leukemia, immunodeficiency, or clotting problems, you could see coding changes coming your way. CMS has posted the HCPCS Public Meeting for Drugs Agenda from May 8, 2012. The Agenda gives a summary of proposed new codes and reveals CMS's preliminary decisions. You may access the Agenda from the Related Links list at the bottom of this site: www.cms.gov/Medicare/Coding/MedHCPCSGenInfo/HCPCSPublicMeetings.html. Remember: The Agenda makes it clear that these are preliminary decisions. Final decisions will be announced in November. The one exception is a RiaSTAP coding change effective July 1, described in the last section. Expect Specific Adcetris Option You may see a new code for Adcetris in 2013: Jxxxx (Injection, brentuximab vedotin, 1 mg). Use: According to the requester, physicians may order Adcetris to treat Hodgkin lymphoma "after failure of autologous stem cell transplant or after [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All